CapsoVision, Inc. Common Stock (CV)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at CapsoVision, Inc. Common Stock.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 4 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 6.60 $ — 28% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 51.5% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.52 | -0.52 – -0.52 | 16 | – | 1 |
| 12/31/2027 | -0.42 | -0.42 – -0.42 | 22 | – | 1 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.13 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.09 | – | 4 | – | -134.40 | -5 | -5 |
| 2025: Q1 | -0.11 | – | 3 | 11.50 | -193.10 | -5 | -5 |
| 2025: Q2 | -0.09 | – | 3 | 16.60 | -139.50 | -5 | -5 |
| 2025: Q3 | -0.16 | – | 4 | 19.30 | -223.90 | -6 | -6 |
| 2025: Q4 | -0.15 | – | 4 | 13.50 | -188.70 | -8 | -13 |
| 2026: Q1 | -0.14 | – | 3 | 0.30 | -251.90 | -6 | -6 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2023 | 10 | -11 | -11 | -0.29 | -11 | -110 | 22 |
| 2024 | 12 | -20 | -20 | -0.52 | -20 | -130 | 17 |
| 2025 | 14 | -26 | -25 | -0.10 | -23 | 13 | 18 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
CapsoVision, Inc., ein Medizintechnikunternehmen, fertigt und vermarktet endoskopische Videobildgebungsgeräte mit Fokus auf die innere Bildgebung des Magen-Darm-Trakts.
| Employees | 99 |
|---|---|
| Headquarters | Saratoga, CA |
| Address | 18805 Cox Avenue, 95070 Saratoga, United States |
| Phone | 408 624 1488 |
| Website | capsovision.com |
| IPO Date | 2. Jul 2025 |
| ISIN | US1409351079 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Kang-Huai Wang | Co-Founder, President, CEO & Director | 1957 |
| David Garcia | Compliance Officer, SVP of Finance, Principal Financial & Accounting Officer | 1975 |
| Douglas Atkinson | Senior Vice President of Global Sales | 1968 |
| Helen Chau | Manager of Human Resources | – |
| Anna Krylova | Corporate Controller | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 17. Jul 2026 | Harari Eliyahou Et Al | 10% Owner | Buy | 61,068 | 6.73 | 410,988 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.